Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Impax Labs Inc (IPXL)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,351,821
  • Shares Outstanding, K 73,870
  • Annual Sales, $ 775,790 K
  • Annual Income, $ -469,290 K
  • 36-Month Beta 1.15
  • Price/Sales 1.74
  • Price/Cash Flow 8.77
  • Price/Book 7.25
  • Price/Earnings ttm 29.05
  • Earnings Per Share ttm 0.63
  • Most Recent Earnings 0.11 on 03/01/18
  • Next Earnings Date 05/09/18
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 12 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/18
See More
  • Average Estimate 0.16
  • Number of Estimates 5
  • High Estimate 0.22
  • Low Estimate 0.11
  • Prior Year 0.11
  • Growth Rate Est. (year over year) +45.45%

Price Performance

See More
Period Period Low Period High Performance
1-Month
17.40 +5.17%
on 05/04/18
20.80 -12.02%
on 05/02/18
-1.45 (-7.34%)
since 04/04/18
3-Month
17.40 +5.17%
on 05/04/18
21.55 -15.08%
on 02/26/18
-1.10 (-5.67%)
since 02/02/18
52-Week
13.05 +40.23%
on 05/08/17
25.70 -28.79%
on 09/21/17
+5.10 (+38.64%)
since 05/04/17

Most Recent Stories

More News
Amneal Announces Favorable Ruling Regarding Patent Validity for Zomig® (zolmitriptan) Nasal Spray

Amneal Pharmaceuticals, Inc. (NYSE: AMRX) announced today that a panel of three Circuit Judges of the U.S. Court of Appeals for the Federal Circuit has affirmed the March 30, 2017 ruling of Judge Richard...

IPXL : 18.30 (unch)
AMRX : 21.39 (-1.11%)
Impax Laboratories, LLC Announces Results of Tender Offer for 2.00% Convertible Senior Notes Due 2022

Impax Laboratories, LLC ("Impax" or the "Company"), a wholly-owned subsidiary of Amneal Pharmaceuticals, Inc. (NYSE: AMRX), announced today the final results of its previously announced cash tender offer...

IPXL : 18.30 (unch)
AMRX : 21.39 (-1.11%)
ANI Pharmaceuticals Completes Acquisition of Generic Products and Assets from Amneal/Impax

ANI Pharmaceuticals, Inc. ("ANI") (Nasdaq: ANIP) today announced that it has completed the acquisition of a portfolio of six generic products, related manufacturing and supply agreements, and equipment...

IPXL : 18.30 (unch)
ANIP : 55.97 (+0.27%)
Amneal and Impax Complete Business Combination

Amneal Pharmaceuticals LLC and Impax Laboratories, Inc. ("Impax") today announced that they have completed their business combination to form Amneal Pharmaceuticals, Inc. ("Amneal" or the "Company"). As...

IPXL : 18.30 (unch)
AMRX : 21.39 (-1.11%)
Apergy Set to Join S&P MidCap 400; 3D Systems to Join S&P SmallCap 600

Apergy Corp. (NYSE: APY) will replace 3D Systems Corp. (NYSE: DDD) in the S&P MidCap 400, and 3D Systems will replace Impax Laboratories Inc. (NASD: IPXL) in the S&P SmallCap 600 effective prior to the...

DDD : 19.03 (-0.99%)
IPXL : 18.30 (unch)
SPGI : 202.26 (-0.21%)
APY : 43.17 (-0.44%)
DOV : 83.79 (+1.02%)
AMRX : 21.39 (-1.11%)
Amneal And Impax Receive FTC Clearance For Business Combination

Amneal Pharmaceuticals LLC and Impax Laboratories, Inc. (NASDAQ: IPXL) today announced that the U.S. Federal Trade Commission (FTC) has cleared the Amneal and Impax business combination, subject to Amneal...

IPXL : 18.30 (unch)
ANIP : 55.97 (+0.27%)
PRGO : 72.47 (+2.94%)
New Strong Sell Stocks for April 26th

Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:

ARES : 20.98 (+0.87%)
CKHUY : 11.3300 (+0.27%)
IPXL : 18.30 (unch)
BWP : 12.05 (unch)
GPT : 27.35 (unch)
Top 5 Companies in the Pharmaceuticals Industry with the Best Relative Performance (PCRX , DERM , IPXL , LCI , MRK )

We looked at the Pharmaceuticals industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength. We look...

DERM : 9.64 (-0.92%)
IPXL : 18.30 (unch)
PCRX : 45.70 (-1.08%)
Blog Exposure - Impax Launched a Generic Version of Estrace(R) Cream

Stock Monitor: Rockwell Medical Post Earnings Reporting

IPXL : 18.30 (unch)
PRGO : 72.47 (+2.94%)
Impax Labs Inc Set to Possibly Rebound After Yesterday's Selloff of 2.37%

Impax Labs Inc (NASDAQ:IPXL) traded in a range yesterday that spanned from a low of $18.35 to a high of $19.15. Yesterday, the shares fell 2.4%, which took the trading range below the 3-day low of $18.45...

IPXL : 18.30 (unch)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 64% Sell with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators mostly agree with the trend.

See More Share

Trade IPXL with:

Business Summary

Impax Laboratories, Inc. is a technology-based, specialty pharmaceutical company engaged in the development, manufacture, and marketing of specialty prescription pharmaceutical products utilizing its own formulation expertise and drug delivery technologies. IMPAX Laboratories is focusing on two key areas,...

See More

Key Turning Points

2nd Resistance Point 19.77
1st Resistance Point 19.03
Last Price 18.30
1st Support Level 17.48
2nd Support Level 16.67

See More

52-Week High 25.70
Fibonacci 61.8% 20.87
Fibonacci 50% 19.38
Last Price 18.30
Fibonacci 38.2% 17.88
52-Week Low 13.05

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar